Biological properties of reverse ankyrin engineered for dimer construction to enhance HIV-1 capsid interaction
Asian Pacific Journal of Allergy and Immunology · 2025
DOI: 10.12932/ap-210122-1310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Pacific Journal of Allergy and Immunology, 2025. Verfasst von On-Anong Juntit und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailan…. Hauptthemen laut MEDLINE: HIV-1, Ankyrins, Capsid Proteins, Capsid.
Abstract (Originalsprache)
BACKGROUND: Assembly and budding in the late-stage of human immunodeficiency virus type 1 (HIV-1) production rely on Gag protein polymerization at the inner leaflet of the plasma membrane. We previously generated a monomeric ankyrin repeat protein (Ank1D4) that specifically interacts with capsid protein (CAp24) of HIV-1, however this protein had modest binding affinity. OBJECTIVE: This study aimed to improve the avidity of Ank1D4 by generating two Ank1D4 dimers: (Ank1D4NC-NC) and its inverted form (Ank1D4NC-CN), with each domain connected by a flexible (G4S)4 linker peptide. METHODS: Binding properties of monomeric and dimeric Ank1D4 was performed by capture enzyme-linked immunosorbent assay (ELISA). Sandwich ELISA was used to examine bifunctional module of dimeric Ank1D4. Ank1D4NC-NC and Ank1D4NC-CN were evaluated using bio-layer interferometry (BLI), compared to monomeric Ank1D4. RESULTS: Similar binding surfaces were observed in both dimers which was comparable with monomeric Ank1D4. The interaction of Ank1D4NC-CN with CAp24 was significantly greater than that of Ank1D4NC-NC and Ank1D4 by capture ELISA. Ank1D4NC-CN also exhibited bifunctionality using a sandwich ELISA. The KD of Ank1D4NC-CN, Ank1D4NC-NC and monomeric Ank1D4 was 3.5 nM, 53.7 nM, and 126.2 nM, respectively using bio-layer interferometry analysis. CONCLUSIONS: This study provides a strategy for increasing Ank1D4 avidity through the construction of novel inverted dimers with a flexible linker. Ank1D4NC-CN may provide an alternative treatment strategy for inhibiting HIV-1 replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
- Center of Biomolecular Therapy and Diagnostic, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
- Center of Innovative Immunodiagnostic Development, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
- Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
- Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Thailand Excellence Center for Tissue Engineering and Stem Cells, Department of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Zitieren
APA
Juntit, O. A., Yasamut, U., Sakkhachornphop, S., Chupradit, K., Thongkum, W., Srisawat, C., Chokepaichitkool, T., Kongtawelert, P., & Tayapiwatana, C. (2025). Biological properties of reverse ankyrin engineered for dimer construction to enhance HIV-1 capsid interaction. Asian Pacific Journal of Allergy and Immunology. https://doi.org/10.12932/ap-210122-1310
Vancouver
Juntit OA, Yasamut U, Sakkhachornphop S, Chupradit K, Thongkum W, Srisawat C, et al. Biological properties of reverse ankyrin engineered for dimer construction to enhance HIV-1 capsid interaction. Asian Pacific Journal of Allergy and Immunology. 2025. doi:10.12932/ap-210122-1310
BibTeX
@article{Juntit2025,
author = {Juntit, On-Anong and Yasamut, Umpa and Sakkhachornphop, Supachai and Chupradit, Koollawat and Thongkum, Weeraya and Srisawat, Chatchawan and Chokepaichitkool, Tawan and Kongtawelert, Prachya and Tayapiwatana, Chatchai},
title = {Biological properties of reverse ankyrin engineered for dimer construction to enhance HIV-1 capsid interaction},
journal = {Asian Pacific Journal of Allergy and Immunology},
year = {2025},
doi = {10.12932/ap-210122-1310}
}
EUVIMED